Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation

  • Am J Hum Genet. 2012 Jul 13;91(1):146-51. doi: 10.1016/j.ajhg.2012.05.004.
Peter M Krawitz  1 ,  Yoshiko Murakami ,  Jochen Hecht ,  Ulrike Krüger ,  Susan E Holder ,  Geert R Mortier ,  Barbara Delle Chiaie ,  Elfride De Baere ,  Miles D Thompson ,  Tony Roscioli ,  Szymon Kielbasa ,  Taroh Kinoshita ,  Stefan Mundlos ,  Peter N Robinson ,  Denise Horn
Affiliations
  • 1. Institute for Medical Genetics and Human Genetics, Charité Universitätsmedizin, Berlin, Germany.
Abstract

Hyperphosphatasia with mental retardation syndrome (HPMRS), an autosomal-recessive form of intellectual disability characterized by facial dysmorphism, seizures, brachytelephalangy, and persistent elevated serum Alkaline Phosphatase (hyperphosphatasia), was recently shown to be caused by mutations in PIGV, a member of the glycosylphosphatidylinositol (GPI)-anchor-synthesis pathway. However, not all individuals with HPMRS harbor mutations in this gene. By exome Sequencing, we detected compound-heterozygous mutations in PIGO, a gene coding for a membrane protein of the same molecular pathway, in two siblings with HPMRS, and we then found by Sanger Sequencing further mutations in another affected individual; these mutations cosegregated in the investigated families. The mutant transcripts are aberrantly spliced, decrease the membrane stability of the protein, or impair enzyme function such that GPI-anchor synthesis is affected and the level of GPI-anchored substrates localized at the cell surface is reduced. Our data identify PIGO as the second gene associated with HPMRS and suggest that a deficiency in GPI-anchor synthesis is the underlying molecular pathomechanism of HPMRS.